JPWO2019180137A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019180137A5
JPWO2019180137A5 JP2020544940A JP2020544940A JPWO2019180137A5 JP WO2019180137 A5 JPWO2019180137 A5 JP WO2019180137A5 JP 2020544940 A JP2020544940 A JP 2020544940A JP 2020544940 A JP2020544940 A JP 2020544940A JP WO2019180137 A5 JPWO2019180137 A5 JP WO2019180137A5
Authority
JP
Japan
Prior art keywords
dna polymerase
amino acid
primer
seq
dntp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020544940A
Other languages
Japanese (ja)
Other versions
JP2021516544A (en
JP7319990B2 (en
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/057080 external-priority patent/WO2019180137A1/en
Publication of JP2021516544A publication Critical patent/JP2021516544A/en
Publication of JPWO2019180137A5 publication Critical patent/JPWO2019180137A5/ja
Application granted granted Critical
Publication of JP7319990B2 publication Critical patent/JP7319990B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (15)

配列番号2と少なくとも90%の配列同一性を有し、かつ対照のDNAポリメラーゼと比較して、メチル化デオキシヌクレオチド三リン酸(dNTP)の組み込み効率が向上したDNAポリメラーゼであって、
配列番号2の640位に対応する前記DNAポリメラーゼのアミノ酸はMであり、
前記対照のDNAポリメラーゼは、前記DNAポリメラーゼと同一のアミノ酸配列を有するが、配列番号2の640位に対応する前記対照のDNAポリメラーゼのアミノ酸はIである、DNAポリメラーゼ。
A DNA polymerase having at least 90% sequence identity with SEQ ID NO: 2 and having improved integration efficiency of methylated deoxynucleotide triphosphate (dNTP) as compared to a control DNA polymerase.
The amino acid of the DNA polymerase corresponding to position 640 of SEQ ID NO: 2 is M.
The control DNA polymerase has the same amino acid sequence as the DNA polymerase, but the amino acid of the control DNA polymerase corresponding to position 640 of SEQ ID NO: 2 is I, a DNA polymerase.
配列番号2の705位に対応する前記アミノ酸はV以外の任意のアミノ酸である、請求項1に記載のDNAポリメラーゼ。The DNA polymerase according to claim 1, wherein the amino acid corresponding to the 705th position of SEQ ID NO: 2 is any amino acid other than V. 配列番号2の705位に対応するアミノ酸はLである、請求項に記載のDNAポリメラーゼ。 The DNA polymerase according to claim 2 , wherein the amino acid corresponding to position 705 of SEQ ID NO: 2 is L. 前記DNAポリメラーゼは配列番号4のアミノ酸配列を含む、請求項に記載のDNAポリメラーゼ。 The DNA polymerase according to claim 1 , wherein the DNA polymerase comprises the amino acid sequence of SEQ ID NO: 4. 前記DNAポリメラーゼは配列番号3のアミノ酸配列を含む、請求項1~のいずれか一項に記載のDNAポリメラーゼ。 The DNA polymerase according to any one of claims 1 to 3 , wherein the DNA polymerase comprises the amino acid sequence of SEQ ID NO: 3. 請求項1~のいずれか一項に記載のDNAポリメラーゼをコードする組換え核酸。 A recombinant nucleic acid encoding the DNA polymerase according to any one of claims 1 to 5 . 請求項に記載の組換え核酸を含む発現ベクター。 An expression vector containing the recombinant nucleic acid according to claim 6 . 請求項1~のいずれか一項に記載のDNAポリメラーゼを提供する少なくとも1個の容器を含む伸長プライマーを生成するためのキット。 A kit for producing an extension primer containing at least one container comprising the DNA polymerase according to any one of claims 1 to 5 . (a)プライマー伸長条件で、所定のポリヌクレオチド鋳型にハイブリダイズ可能なプライマーを提供する容器、
(b)dNTPを提供する容器、および
(c)プライマー伸長に適する緩衝液を提供する容器
からなる群から選択される1個以上の追加の容器をさらに含む、請求項に記載のキット。
(A) A container that provides a primer that can hybridize to a predetermined polynucleotide template under primer extension conditions.
The kit of claim 8 , further comprising one or more additional containers selected from the group consisting of (b) a container providing dNTPs and (c) a container providing a buffer suitable for primer extension.
前記dNTPはメチル化dNTPである、請求項に記載のキット。 The kit according to claim 9 , wherein the dNTP is a methylated dNTP. 請求項1~のいずれか一項に記載のDNAポリメラーゼ、少なくとも1つのプライマー、ポリヌクレオチド鋳型、およびdNTPを含む反応混合物。 A reaction mixture comprising the DNA polymerase according to any one of claims 1 to 5 , at least one primer, a polynucleotide template, and dNTP. 前記ポリヌクレオチド鋳型はRNAまたはDNAである、請求項11に記載の反応混合物。 The reaction mixture according to claim 11 , wherein the polynucleotide template is RNA or DNA . Mg2+をさらに含む、請求項11または12に記載の反応混合物。 The reaction mixture according to claim 11 or 12 , further comprising Mg 2+ . 第2の耐熱性DNAポリメラーゼをさらに含む、請求項1113のいずれか一項に記載の反応混合物。 The reaction mixture according to any one of claims 11 to 13 , further comprising a second thermostable DNA polymerase. 請求項1~のいずれか一項に記載のDNAポリメラーゼを、プライマーの伸長に適する条件で、プライマー、ポリヌクレオチド鋳型、およびヌクレオシド三リン酸と接触させて、それにより伸長プライマーを生成する、プライマー伸長を実施する方法。 Primer for contacting the DNA polymerase according to any one of claims 1 to 5 with a primer, a polynucleotide template, and a nucleoside triphosphate under conditions suitable for primer extension, thereby producing an extension primer. How to perform elongation.
JP2020544940A 2018-03-21 2019-03-21 DNA polymerases that efficiently and effectively incorporate methylated dNTPs Active JP7319990B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862645935P 2018-03-21 2018-03-21
US62/645,935 2018-03-21
PCT/EP2019/057080 WO2019180137A1 (en) 2018-03-21 2019-03-21 Dna polymerases for efficient and effective incorporation of methylated-dntps

Publications (3)

Publication Number Publication Date
JP2021516544A JP2021516544A (en) 2021-07-08
JPWO2019180137A5 true JPWO2019180137A5 (en) 2022-03-31
JP7319990B2 JP7319990B2 (en) 2023-08-02

Family

ID=65995680

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020544940A Active JP7319990B2 (en) 2018-03-21 2019-03-21 DNA polymerases that efficiently and effectively incorporate methylated dNTPs

Country Status (6)

Country Link
US (1) US20210032609A1 (en)
EP (1) EP3768832B1 (en)
JP (1) JP7319990B2 (en)
CN (1) CN111868238A (en)
ES (1) ES2969883T3 (en)
WO (1) WO2019180137A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114574465B (en) * 2022-05-09 2022-08-05 上海众启生物科技有限公司 Polymerase mutant and application thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4666848A (en) 1984-08-31 1987-05-19 Cetus Corporation Polypeptide expression using a portable temperature sensitive control cassette with a positive retroregulatory element
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5079352A (en) 1986-08-22 1992-01-07 Cetus Corporation Purified thermostable enzyme
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5693502A (en) 1990-06-11 1997-12-02 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand inhibitors to DNA polymerases
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
KR100484124B1 (en) * 1994-10-17 2005-09-08 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 DNA Polymerases Having Modified Nucleotide Binding Site for DNA Sequencing
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
EP0834569A1 (en) 1996-10-03 1998-04-08 Roche Diagnostics GmbH Thermostable DNA polymerase from carboxydothermus hydrogenoformans
EP0866071B1 (en) 1997-03-20 2004-10-20 F. Hoffmann-La Roche Ag Modified primers
US6228628B1 (en) 1997-07-09 2001-05-08 Roche Molecular Systems Mutant chimeric DNA polymerase
EP0921196A1 (en) 1997-12-02 1999-06-09 Roche Diagnostics GmbH Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
US6329178B1 (en) 2000-01-14 2001-12-11 University Of Washington DNA polymerase mutant having one or more mutations in the active site
AU2001241621B2 (en) * 2000-02-23 2005-08-25 City Of Hope Pyrophosphorolysis activated polymerization (PAP): application to allele-specific amplification and nucleic acid sequence determination
US7179590B2 (en) 2000-04-18 2007-02-20 Roche Molecular Systems, Inc High temperature reverse transcription using mutant DNA polymerases
US7256019B2 (en) 2001-08-29 2007-08-14 Ge Healthcare Bio-Sciences Corp. Terminal phosphate blocked nucleoside polyphosphates
US7148049B2 (en) 2002-04-02 2006-12-12 Roche Molecular Systems, Inc. Thermostable or thermoactive DNA polymerase molecules with attenuated 3′-5′ exonuclease activity
US7947817B2 (en) 2003-06-30 2011-05-24 Roche Molecular Systems, Inc. Synthesis and compositions of 2'-terminator nucleotides
US7572581B2 (en) 2003-06-30 2009-08-11 Roche Molecular Systems, Inc. 2′-terminator nucleotide-related methods and systems
US20060172324A1 (en) 2005-01-28 2006-08-03 Roche Molecular Systems, Inc. Methods of genotyping using differences in melting temperature
GB0509508D0 (en) * 2005-05-10 2005-06-15 Solexa Ltd Improved polymerases
US20110294168A1 (en) 2006-10-18 2011-12-01 Roche Molecular Systems, Inc. Dna polymerases and related methods
US8962293B2 (en) 2006-10-18 2015-02-24 Roche Molecular Systems, Inc. DNA polymerases and related methods
US8208381B2 (en) 2007-07-27 2012-06-26 Eg Innovations Pte. Ltd. Root-cause approach to problem diagnosis in data networks
US9193959B2 (en) * 2010-04-16 2015-11-24 Roche Diagnostics Operations, Inc. T7 RNA polymerase variants with enhanced thermostability
JP5926248B2 (en) * 2010-06-18 2016-05-25 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft DNA polymerase with increased 3 'terminal mismatch discrimination
ES2569723T3 (en) * 2011-12-08 2016-05-12 F. Hoffmann-La Roche Ag DNA polymerases with enhanced activity
ES2716277T3 (en) * 2011-12-08 2019-06-11 Hoffmann La Roche DNA polymerases with enhanced activity
JP6144697B2 (en) 2011-12-08 2017-06-07 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft DNA polymerase with improved activity
JP6356694B2 (en) * 2012-12-13 2018-07-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft DNA polymerase with improved activity

Similar Documents

Publication Publication Date Title
US10619190B2 (en) Compositions, methods, systems and kits for target nucleic acid enrichment
Craw et al. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review
NO340891B1 (en) Double specificity oligonucleotide
JP3867926B2 (en) Nucleic acid amplification method
US20030157549A1 (en) Use of predetermined nucleotides having altered base pairing characteristics in the amplification of nucleic acid molecules
JP6455864B2 (en) Polynucleotide and use thereof
EP2099936B1 (en) Improved multiplex nucleic acid amplification using blocked primers
JP2010532979A5 (en)
JP6021230B2 (en) Method for quantifying human DNA using internal controls
JP2005521422A5 (en)
WO2006074334A2 (en) Identification of rna targets using helicases
JP2018516594A5 (en)
US20200224260A1 (en) Method for suppressing non-specific amplification products in nucleic acid amplification technologies
US20240084363A1 (en) Method for quantifying and/or detecting human male dna
CN1313893A (en) FY7 polymerase
JPWO2019180137A5 (en)
US7501254B2 (en) Methods and compositions for amplification and capture of nucleic acid sequences
US9657337B2 (en) Reaction buffer for microarray
WO2005083120A1 (en) Method for amplifying members of a gene family
US9988659B1 (en) In vivo conversion of nucleosides in plasmid DNA
JP4942160B2 (en) Method for isothermal amplification of nucleic acid using RecA protein
JPWO2020053327A5 (en)
JPWO2020234200A5 (en)
KR101096570B1 (en) Oligonucleotides for Detection of Dandruff-associated the Yeasts of the Genus Malassezia
WO1999037820A1 (en) An exponential nucleic acid amplification method using a single primer of opposing polarity